Vir Biotechnology, Inc. Common Stock
€7.933
EUR
Last updated on --.
24h volume758.15K
24h highest8.2071 EUR
24h lowest7.9043 EUR
24h Price movement-1.66%
VIR recent prices
24 Hours
-1.66%-€0.13418
30 days
-9.68%-€0.8558
60 days
+9.75%+€0.70958
90 days
+2.15%+€0.16772
Key data
Previous close8.0677 EUR
Market cap1.29B EUR
Volume758.15K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-2.2363 EUR
Net income (FY)-376.71M EUR
Revenue (FY)58.97M EUR
Last report dateFeb 23, 2026
About Vir Biotechnology, Inc. Common Stock
HeadquartersSAN FRANCISCO
Employees (FY)367.00
Revenue per employee (FY)160.67K EUR
Net income per employee (FY)-1.03M EUR
Listed onNasdaq
VIR conversion tables
 |  |
|---|---|
| 0.5 VIR | 3.966 EUR |
| 1 VIR | 7.933 EUR |
| 5 VIR | 39.66 EUR |
| 10 VIR | 79.33 EUR |
| |
|---|---|
| 0.5 EUR | 0.063023 VIR |
| 1 EUR | 0.12605 VIR |
| 5 EUR | 0.63023 VIR |
| 10 EUR | 1.260 VIR |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
VIR is trading at €7.933, -1.66% over the last 24 hours. Track live moves on the price chart at the top of this page.
The VIR stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. VIR is currently trading at €7.933, -1.66% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on VIR price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. VIR's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from VIR; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against VIR's historical range and other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.
Vir Biotechnology, Inc. Common Stock's market cap is currently 1.29B EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume758.15K
24h highest8.2071 EUR
24h lowest7.9043 EUR
24h Price movement-1.66%
Start trade with VIR Perpetual
Sign up to trade